[Serodiagnosis and epidemiology of a California encephalitis group of infections in the Ryazan' region]. 1995

A M Butenko, and V G Demikhov, and M S Nedialkova, and N A Lavrova

Blood sera of 221 healthy residents of 4 districts of Ryazan region were tested in the neutralization test (NT) with Tahyna and Inkoo viruses. The sum of positive responses in the region was 40.7% on an average, this indicating numerous contacts of the local population with these agents. Blood sera of 520 patients with acute seasonal (May-September) fevers and neuroinfections were tested for antibodies to Tahyna and Inkoo viruses in serologic tests (NT and MAC-ELISA-IgM-antibody capture method). Etiologic relationship of the diseases with Tahyna and Inkoo viruses was detected in 51 (9.8%) cases. The patients developed two types of specific immune response, primary or secondary. The best diagnostic result was attained in testing paired sera of patients in NT and MAC-ELISA. MAC-ELISA helped etiologically diagnose the disease after a single testing of a blood serum collected in the acute period of the disease. Inkoo infection was more incident in subjects aged 21 to 40 in May and July-August. The majority of cases of Tahyna infection were diagnosed in subjects aged under 20 in June and July. The incubation period was from 3 to 7 days, the morbidity was sporadic.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D004670 Encephalitis, California A viral infection of the brain caused by serotypes of California encephalitis virus (ENCEPHALITIS VIRUS, CALIFORNIA) transmitted to humans by the mosquito AEDES triseriatus. The majority of cases are caused by the LA CROSSE VIRUS. This condition is endemic to the midwestern United States and primarily affects children between 5-10 years of age. Clinical manifestations include FEVER; VOMITING; HEADACHE; and abdominal pain followed by SEIZURES, altered mentation, and focal neurologic deficits. (From Joynt, Clinical Neurology, 1996, Ch26, p13) California Viral Encephalitis,Jamestown Canyon Virus Disease,Jamestown Canyon Virus Encephalitis,Tahyna Virus Disease,Tahyna Virus Infection,California Encephalitis,California Encephalitis Virus Infection,Encephalitis, California, Viral,La Crosse Encephalitis,La Crosse Encephalitis Virus Infection,Viral Encephalitis, California,Disease, Tahyna Virus,Encephalitis, California Viral,Encephalitis, La Crosse,Infection, Tahyna Virus,Virus Disease, Tahyna,Virus Infection, Tahyna
D004797 Enzyme-Linked Immunosorbent Assay An immunoassay utilizing an antibody labeled with an enzyme marker such as horseradish peroxidase. While either the enzyme or the antibody is bound to an immunosorbent substrate, they both retain their biologic activity; the change in enzyme activity as a result of the enzyme-antibody-antigen reaction is proportional to the concentration of the antigen and can be measured spectrophotometrically or with the naked eye. Many variations of the method have been developed. ELISA,Assay, Enzyme-Linked Immunosorbent,Assays, Enzyme-Linked Immunosorbent,Enzyme Linked Immunosorbent Assay,Enzyme-Linked Immunosorbent Assays,Immunosorbent Assay, Enzyme-Linked,Immunosorbent Assays, Enzyme-Linked
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

A M Butenko, and V G Demikhov, and M S Nedialkova, and N A Lavrova
March 1976, The Journal of infectious diseases,
A M Butenko, and V G Demikhov, and M S Nedialkova, and N A Lavrova
July 1939, American journal of public health and the nation's health,
A M Butenko, and V G Demikhov, and M S Nedialkova, and N A Lavrova
January 1970, Zentralblatt fur Bakteriologie, Parasitenkunde, Infektionskrankheiten und Hygiene. 1. Abt. Medizinisch-hygienische Bakteriologie, Virusforschung und Parasitologie. Originale,
A M Butenko, and V G Demikhov, and M S Nedialkova, and N A Lavrova
January 1989, Voprosy virusologii,
A M Butenko, and V G Demikhov, and M S Nedialkova, and N A Lavrova
February 1990, Nihon rinsho. Japanese journal of clinical medicine,
A M Butenko, and V G Demikhov, and M S Nedialkova, and N A Lavrova
August 1955, Zentralblatt fur Bakteriologie, Parasitenkunde, Infektionskrankheiten und Hygiene. 1. Abt. Medizinisch-hygienische Bakteriologie, Virusforschung und Parasitologie. Originale,
A M Butenko, and V G Demikhov, and M S Nedialkova, and N A Lavrova
September 1992, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America,
A M Butenko, and V G Demikhov, and M S Nedialkova, and N A Lavrova
July 1971, Journal of immunology (Baltimore, Md. : 1950),
A M Butenko, and V G Demikhov, and M S Nedialkova, and N A Lavrova
July 1967, The American journal of tropical medicine and hygiene,
A M Butenko, and V G Demikhov, and M S Nedialkova, and N A Lavrova
March 1966, The American journal of tropical medicine and hygiene,
Copied contents to your clipboard!